Boston Scientific’s spinal cord stimulators approved for non-surgical back pain
February 7, 2024
FDA backing for the Wavewriter SCS systems allows the company to challenge Abbott and Nevro.
FDA backing for the Wavewriter SCS systems allows the company to challenge Abbott and Nevro.
New technique made human T cells 100 times more potent at killing cancer cells